D
NeuroOne Medical Technologies Corporation NMTC
$0.652 $0.04858.04% NASDAQ
Recommendation
Prev Close
$0.652
Volume
317,659
Avg Vol (90D)
288,433
Market Cap
$30.90M
Dividend & Yield
--
52-Week Range
$0.3954 - $1.39
P/E (TTM)
--
EPS (TTM)
-$0.2659
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
NeuroOne Completes FDA Submission for the OneRF Trigeminal Nerve Ablation System to Treat Facial Pain
4/23/2025 - Globe Newswire
NeuroOne Medical Technologies Corp (NMTC) Q1 2025 Earnings Call Highlights: Regulatory Success ...
4/21/2025 - GuruFocus
NeuroOne Issues Letter to Shareholders
4/16/2025 - Globe Newswire
NeuroOne OneRF Technology Success Story Featured on Fox News
4/14/2025 - Globe Newswire
Insider Buyers Lose US$21k As NeuroOne Medical Technologies Sheds US$6.2m
4/10/2025 - Simply Wall St
Chief Financial Officer of NeuroOne Medical Technologies Ronald McClurg Buys More Stock
4/10/2025 - Simply Wall St
Insider Buying: NeuroOne Medical Technologies Co. (NASDAQ:NMTC) CEO Acquires 100,000 Shares of Stock
4/8/2025 - Ticker Report
Nasdaq Dips 5%; NeuroOne Medical Technologies Shares Plummet
4/4/2025 - Benzinga
NeuroOne Medical Technologies Corporation Announces Pricing of $8. ...
4/4/2025 - GuruFocus
NeuroOne Medical Technologies prices $8 million public offering of common stock
4/4/2025 - SeekingAlpha.com: All News
NeuroOne Medical Technologies Corporation Announces Pricing of $8.0 Million Public Offering of Common Stock
4/4/2025 - Globe Newswire
NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock
4/3/2025 - GuruFocus
NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock
4/3/2025 - Globe Newswire
NeuroOne CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today's Marketplace - Update
3/18/2025 - Globe Newswire
NeuroOne CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today's Marketplace
3/18/2025 - Globe Newswire
NeuroOne Accelerates Timeline of 510(k) Submission to FDA for the OneRF Trigeminal Nerve Ablation System to Treat Facial Pain
3/11/2025 - Globe Newswire
NeuroOne to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
3/5/2025 - Globe Newswire
NeuroOne Medical Technologies (NASDAQ:NMTC) Announces Earnings Results
2/13/2025 - Ticker Report
NeuroOne Medical Technologies Corp (NMTC) Q1 2025 Earnings Call Highlights: Record Revenue and ...
2/13/2025 - GuruFocus
Q1 2025 NeuroOne Medical Technologies Corp Earnings Call Transcript
2/13/2025 - GuruFocus
NeuroOne Medical Technologies Corporation (NMTC) Q1 2025 Earnings Call Transcript
2/12/2025 - SeekingAlpha
NeuroOne Medical Technologies Corporation (NMTC) Q1 2025 Earnings Call Transcript
2/12/2025 - Seeking Alpha: Transcripts
NeuroOne Medical Technologies Corp Reports Q1 FY2025 Earnings: EPS at $0.06, Revenue Reaches $6. ...
2/12/2025 - GuruFocus
NeuroOne Reports First Quarter Fiscal Year 2025 Financial Results and Provides Corporate Update
2/12/2025 - Globe Newswire
NeuroOne to Report First Quarter Fiscal Year 2025 Financial Results on Wednesday, February 12 at 8:30 a.m. Eastern Time
2/5/2025 - Globe Newswire
Income Statement
Total Revenue (TTM)
$5.75M
EBITDA (TTM)
-$6.53M
EBIT (TTM)
-$6.79M
Net Income (TTM)
-$7.19M
Balance Sheet
Total Assets (Q)
$6.49M
Total Debt (Q)
$341.50K
Total Liabilities (Q)
$3.56M
Book Value Per Share (Q)
$0.0952
Cash Flow
Cash from Operations (TTM)
-$6.99M
Cash from Investing (TTM)
-$107.50K
Cash from Financing (TTM)
$5.56M
Net Change in Cash (TTM)
-$1.55M
Filings
Filing Date
Wednesday, February 12, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Loading...
Beta
1.73
7-Day Total Return
15.48%
30-Day Total Return
-39.63%
60-Day Total Return
-43.30%
90-Day Total Return
-14.23%
Year to Date Total Return
-20.95%
1-Year Total Return
-42.30%
2-Year Total Return
-55.95%
3-Year Total Return
-13.04%
5-Year Total Return
-90.94%
52-week Low
Apr 09, 2025 - $0.3954
52-week High
Jan 24, 2025 - $1.39
Valuation
Market Cap
$30.90M - Nano Cap
Enterprise Value
$30.10M
Price/Sales (TTM)
3.50
Price/Book (Q)
6.85
Dividends and Shares
Shares Outstanding
30.88M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
nmtc1.com
Phone Number
952 426 1383
Address
7599 Anagram Drive
Eden Prairie, MN 55344
Country
United States
Year Founded
--
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the... more
NASDAQ 04/25/2025 4:00PM Eastern Quotes delayed